189 related articles for article (PubMed ID: 1667557)
1. [Neurotoxicity in chemotherapy].
Kopp K; Hansen SW
Sygeplejersken; 1991 Dec; 91(49):4-8. PubMed ID: 1667557
[No Abstract] [Full Text] [Related]
2. [Neurotoxicity with cytostatic therapy: a review].
Cerny T; Meier C
Schweiz Med Wochenschr; 1989 Aug; 119(34):1137-47. PubMed ID: 2554491
[TBL] [Abstract][Full Text] [Related]
3. Neurologic complications of cancer chemotherapy.
Sul JK; Deangelis LM
Semin Oncol; 2006 Jun; 33(3):324-32. PubMed ID: 16769421
[TBL] [Abstract][Full Text] [Related]
4. Neurotoxicity of commonly used antineoplastic agents (second of two parts).
Weiss HD; Walker MD; Wiernik PH
N Engl J Med; 1974 Jul; 291(3):127-33. PubMed ID: 4365666
[No Abstract] [Full Text] [Related]
5. [Neurologic complications of chemotherapy (vincristine etc.)].
Nomura K; Ohno R
Ryoikibetsu Shokogun Shirizu; 1999; (27 Pt 2):576-81. PubMed ID: 10434725
[No Abstract] [Full Text] [Related]
6. [Neurological complications of treatments with vincristine. Clinical study of 100 patients treated with vincristine].
Goldstein B; Lhuillier M
Ann Med Interne (Paris); 1974; 125(6-7):571-6. PubMed ID: 4374109
[No Abstract] [Full Text] [Related]
7. [Lesions of the nervous system in subjects with malignant neoplasms].
Sallusto L; De Marco S; Gaita D; Pignatelli F; Lincesso F
Acta Neurol (Napoli); 1981 Feb; 3(1):128-41. PubMed ID: 6264752
[No Abstract] [Full Text] [Related]
8. [Neurotoxicity and dermatologic toxicity of cancer chemotherapy].
Nakane M
Gan To Kagaku Ryoho; 2006 Jan; 33(1):29-33. PubMed ID: 16410694
[TBL] [Abstract][Full Text] [Related]
9. Central and peripheral nervous system toxicity of common chemotherapeutic agents.
Sioka C; Kyritsis AP
Cancer Chemother Pharmacol; 2009 Apr; 63(5):761-7. PubMed ID: 19034447
[TBL] [Abstract][Full Text] [Related]
10. [Prevention and treatment of neurological toxicity. Nursing aspects].
Peri A; Catalano V; Di Luca L
Suppl Tumori; 2004; 3(4):S113-4. PubMed ID: 15206233
[No Abstract] [Full Text] [Related]
11. [Toxic polyneuropathies].
Kaeser HE
Internist (Berl); 1984 Oct; 25(10):629-36. PubMed ID: 6389421
[No Abstract] [Full Text] [Related]
12. Leading work-related diseases and injuries--United States.
Centers for Disease Control (CDC)
MMWR Morb Mortal Wkly Rep; 1986 Feb; 35(8):113-6, 121-3. PubMed ID: 3003556
[No Abstract] [Full Text] [Related]
13. [Neurological syndromes caused by hemoblastosis, including infectious and iatrogenic complications affecting the nervous system].
Quattrin S; Izzolino R; Buscaino GA
Acta Neurol (Napoli); 1981 Feb; 3(1):94-105. PubMed ID: 6264758
[No Abstract] [Full Text] [Related]
14. [Nervous system lesions in subjects with malignant neoplasms].
Sallusto L; De Marco S; Gaita D; Pignatelli F; Lincesso F
Acta Neurol Quad (Napoli); 1981; 42():128-41. PubMed ID: 6267863
[No Abstract] [Full Text] [Related]
15. Neurotoxicity of cancer chemotherapy.
Dropcho EJ
Semin Neurol; 2010 Jul; 30(3):273-86. PubMed ID: 20577934
[TBL] [Abstract][Full Text] [Related]
16. Neurotoxic substances.
Le Quesne PM
Mod Trends Neurol; 1975; 6():83-97. PubMed ID: 172775
[No Abstract] [Full Text] [Related]
17. [Neurotoxicity of antineoplastic antimetabolites and antineoplastic antibiotics].
Morimatsu M
Ryoikibetsu Shokogun Shirizu; 1999; (27 Pt 2):571-5. PubMed ID: 10434724
[No Abstract] [Full Text] [Related]
18. Neurotoxicity in cancer chemotherapy: vinca alkaloids.
Lobert S
Crit Care Nurse; 1997 Aug; 17(4):71-9. PubMed ID: 9325775
[No Abstract] [Full Text] [Related]
19. Neurologic complications of chemotherapy and other newer and experimental approaches.
Soffietti R; Trevisan E; Rudà R
Handb Clin Neurol; 2014; 121():1199-218. PubMed ID: 24365412
[TBL] [Abstract][Full Text] [Related]
20. Solvents and neurotoxicity.
White RF; Proctor SP
Lancet; 1997 Apr; 349(9060):1239-43. PubMed ID: 9130958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
